#United States #New York #Halper Sadeh #ATXS #PCH

Halper Sadeh LLC Investigates ATXS, PCH, and RYN on Behalf of Shareholders

In a significant move that could impact numerous investors, Halper Sadeh LLC, a law firm known for advocating investor rights, is investigating several companies including Astria Therapeutics, Inc. (NASDAQ: ATXS), PotlatchDeltic Corporation (NASDAQ: PCH), and Rayonier Inc. (NYSE: RYN). This investigation focuses on potential violations of federal securities laws and breaches of fiduciary duties owed to shareholders.

The primary concern arises from Astria Therapeutics' proposed sale to BioCryst Pharmaceuticals, which involves a cash transaction of $8.55 per share accompanied by 0.59 shares of BioCryst's common stock. For shareholders of Astria Therapeutics, this transaction poses questions about the fairness of the offer and whether their interests are adequately protected. Halper Sadeh LLC is reaching out to these shareholders to inform them of their legal rights and available options.

Similarly, the investigation extends to PotlatchDeltic Corporation, which is in the process of being sold to Rayonier Inc. PotlatchDeltic shareholders would receive 1.7339 common shares of Rayonier in exchange for each share they own, resulting in PotlatchDeltic's shareholders owning approximately 46% of the merged entity, should the transaction close.

On the other hand, Rayonier Inc.'s shareholders are projected to own around 54% of the combined company after the merger. Given the potential shifts in ownership percentages, shareholders from both companies may seek legal counsel regarding their rights as the deal progresses.

Halper Sadeh LLC is dedicated to ensuring that shareholders receive adequate disclosures and fair considerations in these transactions. They may advocate for increased compensation or additional information regarding the mergers' implications on shareholders. Importantly, the firm offers to manage these actions on a contingency basis, meaning that clients will not bear upfront costs for legal fees unless they achieve a favorable outcome.

This investigative effort aligns with Halper Sadeh LLC's broader mission of representing investors worldwide affected by securities fraud and corporate malfeasance. The firm has a proven track record, having secured millions in recoveries for defrauded investors while helping to enforce significant corporate reforms.

For any shareholders of Astria Therapeutics, PotlatchDeltic, or Rayonier who wish to know more about their legal rights and options, Halper Sadeh LLC invites them to reach out for a complimentary consultation. Interested parties can contact attorneys Daniel Sadeh or Zachary Halper directly at (212) 763-0060, or via email at [email protected] or [email protected]. It's imperative for shareholders to stay informed and proactive in defending their financial interests, especially in light of impending corporate mergers and acquisitions that could reshape their investment landscape.

Halper Sadeh LLC is not only focused on this specific investigation; they continue to monitor other companies for similar compliance issues, ensuring that shareholder rights remain safeguarded in the ever-evolving financial market. This ongoing commitment highlights the essential role of legal oversight in corporate transactions and emphasizes the need for transparency and accountability in the business sector.